Pharma updates from the Pharmalot campus via the Pharmalittle newsletter
A court in Kenya on Friday suspended a U.S. plan to establish a quarantine facility for Americans exposed to a rare type of Ebola virus spreading in northeastern Congo.
Pharma updates from the Pharmalot campus via the Pharmalittle newsletter
Pfizer invests billions to buy Chinese drugs, WHO maps experimental response to Ebola outbreak, and other biotech news from The Readout
State AG alleges UnitedHealthcare claimed some members were sicker to boost its profits.
The growing Ebola outbreak, the unknowns of microdosing GLP-1s, and more health news from Morning Rounds
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
The order came after U.S. officials said that a 50-bed facility was being established in the African country to house American citizens exposed to the virus.
Long term, we don’t know what tiny doses of GLP-1s for cosmetic weight loss can do, writes a weight-loss doctor.
Jamie Justice of XPRIZE Healthspan on the most promising research and "purely scammy" treatments in the world of longevity.
The babies were part of a vaccine trial for a respiratory virus in the 1960s and died shortly after. Their families said they had been unaware of the trial until recently.
The U.S. is taking extraordinary steps to keep Ebola out. But its policies may create risks for Americans infected overseas and discourage volunteers from responding to the outbreak.
Biotech is producing scientific breakthroughs that once seemed impossible. But according to longtime industry executive Jeremy Levin, the institutions that support these advances, from regulators, to investors, and even public…
This week on "The Readout LOUD," longtime biotech exec Jeremy Levin talks about his new book and the industry's strategic turning point. Listen now.
We still have a lot of questions about Trump's MFN deals with pharma companies.
“Infectious disease threats during the World Cup will almost certainly look much more familiar than frightening headlines suggest,” writes Krutika Kuppalli.
In this edition of STAT Health Tech: A new wave of blood pressure monitoring wearables, Stanford asking patients about AI, and more.
Most people recover from the infection, but it poses great risks for those who don’t. A new drug may cure 1 in 5 of these patients.
In this morning's Pharmalittle roundup, we're reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies, and more.
Strong results from GSK's hepatitis B drug, engineered heart patches, and more biotech news from The Readout
Uganda closes its border, a Christian substitute for insurance, and more health news from Morning Rounds
Wearables with unvetted blood pressure measuring tech are flooding the market after the FDA relaxed oversight of wellness devices.
Here's what to watch for at ASCO, cancer research's big meeting, in Chicago.
As predictive medicine advances, legal scholars warn that decades-old federal guidelines could set up a potential clash between your genes and your job.
An experimental GSK drug helped 1 in 5 patients with chronic hepatitis B achieve what's known as a functional cure, vastly outpacing current treatments.
The public is about to get its first look at the prices of drugs launched since President Trump struck his most-favored-nation deals with 17 drugmakers.
A stem cell-based heart patch improved pumping in a small trial for advanced heart failure. "Very good first step," researcher says.
Drew Altman, who transformed KFF from a little-known family foundation to a major source of U.S. health policy research, will step down at the end of the year.
“This erosion of our strength is a loss for the nation,” writes MIT President Sally Kornbluth.
The business of living forever, Chan Zuckerberg Biohub's AI protein model, and other biotech news from The Readout
The FDA extended the decision deadline for an experimental breast cancer pill from AstraZeneca after an advisory panel voted against the drug
In this edition of AI Prognosis, Brittany Trang takes a look at patients' role in how Stanford Health Care adopts AI tools, and more health AI news.
The conference where death is (theoretically) optional, new trends among undocumented patients, and more health news from Morning Rounds
“Trump has willingly exposed an entire generation of children to Big Tobacco’s nicotine addiction,” writes Sen. Dick Durbin.
Stanford Health Care started asking patients about new AI tools before they are implemented. Here's what patients are telling them.
“Science itself is inherently resilient — that is, after all, why it’s science,” writes Jonathan Jackson.
Inside the longevity conference that brings together founders, investors, biohackers, and the generally death-averse to discuss how to forestall — or even beat — our demise.
If you've been vaccinated against Covid-19, some patients might not want your donated blood.
Researchers found that drinking guava juice may significantly improve anemia by helping the body absorb iron more efficiently. In a review of 17 studies, women and teenage girls who consumed guava juice — especially with iron supplements — experienced noticeable increases in hemoglobin levels. Since guava contains far more vitamin C than oranges, scientists believe it could become a simple, affordable nutrition tool in regions where anemia is widespread.
Scientists in Japan have created powerful new vitamin K-based compounds that may help the brain regenerate lost neurons — a breakthrough that could one day change how diseases like Alzheimer’s and Parkinson’s are treated. By combining vitamin K with components related to vitamin A, the researchers developed compounds that were about three times more effective at turning neural stem cells into neurons than natural vitamin K alone.
In past outbreaks, Americans exposed to the virus were sent home to be treated in state-of-the-art facilities. The Trump administration has already flown some U.S. citizens to Europe for treatment.
Try another keyword or clear the search box.